Skip to main content
OpenTrials
Completed

NCT Number: NCT00109369

Vermont Diabetes Information System

The Vermont Diabetes Information System (VDIS) is a registry-based decision support and reminder system based on the Chronic Care Model and targeted to primary care physicians and their patients with diabetes. It will be evaluated by a randomized, controlled study in 60 Primary Care practices in Vermont and nearby New York.

Completed

Looking for future studies?

Notify Me

Key information

About this study

The long-term goal of the Vermont Diabetes Information System is to reduce morbidity and mortality from diabetes mellitus. The project will implement and evaluate a state-wide system to support evidence-based disease management by primary care providers, their practices, and their patients in the community. The primary study question is: "What is the effect of a Diabetes Information System (including education, feedback and decision support) upon disease control measured by glycated hemoglobin?" Secondary questions address the effect of the system upon adherence to guideline recommendations, blood pressure control, patient satisfaction, medication use, and functional status. We hypothesize that the information system will result in improvements in the process and outcomes of clinical care. There are two specific aims:

Aim 1: Implement the Diabetes Information System. Objective 1.1: Develop a registry of patients with diabetes in primary care practices in Vermont; Objective 1.2: Provide education and feedback to providers regarding their patients with diabetes; Objective 1.3: Deliver decision support (flow sheets, alerts and reminders) based on the registry and targeted at primary care providers and patients, to prompt ideal management of diabetes.

Aim 2: Assess the Diabetes Information System. Objective 2.1: Assess disease control and guideline adherence by examining registry data in all subjects in a prospective, two-year, randomized, controlled trial in 60 primary care practices; Objective 2.2: Assess outcomes (blood pressure control, obesity, functional status, symptoms, medication use, and satisfaction) by interview and examination in a sub-sample of patients from the controlled trial.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adult
  • Diabetes confirmed by Primary Care provider

Exclusion criteria

  • Severe dementia
  • Nursing home resident

Treatment and study plan

Information and decision support for providers and patients

Other

Laboratory-based decision support, reminders, and population report cards.

Other names: Vermedx Diabetes Information System

Primary outcomes

  1. Glycemic control

    Time frame: 2 years

Secondary outcomes

  1. Processes of care

    Time frame: 2 years

  2. Blood pressure control

    Time frame: 2 years

  3. Hypercholesterolemia

    Time frame: 2 years

  4. Adherence to Practice Guidelines

    Time frame: 2 years

  5. Quality of life

    Time frame: 2 years

  6. Healthcare utilization

    Time frame: 2 years

  7. Patient satisfaction

    Time frame: 2 years

  8. Medication use

    Time frame: 2 years

  9. Functional status

    Time frame: 2 years

Sponsors and collaborators

Lead sponsor

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Nih

Collaborators

  • Vermont Program for Quality in Health Care

Registry information

Important dates

Study start
2003
Study completion
2007
First posted
Apr 27, 2005
Registry last updated
Feb 1, 2011

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.